https://www.thebodypro.com/author/theo-smart

Latest by Theo Smart

Hepatitis C Risk Among HIV-Negative Gay Men: Two Studies From ICAAC 2014 Img
Hepatitis C

Hepatitis C Risk Among HIV-Negative Gay Men: Two Studies From ICAAC 2014

Two studies examine the often overlooked hepatitis C (HCV) risk among HIV-negative men who have sex with men (MSM). While the incidence of HCV doesn’t appear to be great, screening is still uncommon and we may just be beginning to identify new cases....

Hepatitis C Regimen, 3D, Cures 99% of Patients, With or Without Ribavirin Img
Conference Coverage

Hepatitis C Regimen, 3D, Cures 99% of Patients, With or Without Ribavirin

An oral, interferon-free combination of three drugs (ABT-450, ombitasvir and dasabuvir), administered with or without ribavirin, achieved a sustained virologic response 12 weeks post treatment (SVR12) in 99% of patients with chronic hepatitis C.

Short-Term Weight Gain Associated With Increase in CVD and Diabetes Post-ART in HIV Cohort Img
Conference Coverage

Short-Term Weight Gain Associated With Increase in CVD and Diabetes Post-ART in HIV Cohort

Data from a large cohort reveal much variability in mean weight gains after initiating ART, depending on the weight category before going on treatment.

Promo Image
Tuberculosis

Action Needed Against TB/HIV and the MDR- and XDR-TB Crisis

A TAG-sponsored forum in South Africa brought together scientists, policy makers, and community activists to discuss multidrug resistant and extensively drug resistant TB and HIV and to identify steps to address the growing crisis.

"Now that we know...

Promo Image
Tuberculosis

Faster TB Test for Resource-Limited Settings

Published Feb 2, 2007 on AIDSmap.com

A large multicenter study conducted in Honduras and Brazil has shown that a new and relatively simple technique to detect active tuberculosis (TB), the microscopic observation drug susceptibility (MODS) test, is ...

Promo Image

Mother-to-Child Transmission: How Will AZT and Nevirapine Use for MTCT Affect Future Treatment?

Two studies in the November 1, 2003 edition of the Journal of Acquired Immune Deficiency Syndromes [JAIDS] address the issue of drug resistance in women taking antiretroviral prophylaxis to prevent mother-to-child transmission [MTCT] of HIV. On...

Promo Image

Once-A-Day Dosing: Balancing Convenience and Effectiveness

Nucleoside/tide Analogs Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Protease Inhibitors (PIs) Once-Daily Combination Regimens The Variable Patient

The era of once-a-day anti-HIV therapy is upon us with five antiretrovirals app...